Cargando…
Ligustrazine inhibits the viability and motility of colon cancer cells
BACKGROUND: Despite the advances in the diagnosis and treatment of colon cancer, the disease remains a major threat worldwide. Ligustrazine (LSZ) is an alkaloid with anti-tumor activity. This study aimed to elucidate the anti-tumor qualities of LSZ on colon cancer cells in vitro and vivo, as well as...
Autores principales: | Chen, Xiaochao, Yang, Xiangdong, Mu, Jiefei, Yue, Chaochi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797917/ https://www.ncbi.nlm.nih.gov/pubmed/35117686 http://dx.doi.org/10.21037/tcr-20-940 |
Ejemplares similares
-
Ligustrazine Inhibits the Migration and Invasion of Renal Cell Carcinoma
por: Zhang, Xufeng, et al.
Publicado: (2023) -
Pharmacokinetic study on the effect of ligustrazine–tangeretin co‐administration on the pharmacokinetics of ligustrazine and its potential mechanism in rats
por: Liu, Dandan, et al.
Publicado: (2023) -
Ligustrazine monomer against cerebral ischemia/reperfusion injury
por: Gao, Hai-jun, et al.
Publicado: (2015) -
Inhibiting Cell Viability and Motility by Layer-by-Layer
Assembly and Biomineralization
por: Wei, Yan, et al.
Publicado: (2020) -
Inhibition of BAMBI reduces the viability and motility of colon cancer via activating TGF-β/Smad pathway in vitro and in vivo
por: Yu, Wenzhen, et al.
Publicado: (2017)